Karani Asset Management LLC Novo Nordisk A S Transaction History

Karani Asset Management LLC

$93.7 Million
Q1 2025

A detailed history of Karani Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Karani Asset Management LLC holds 30,632 shares of NVO stock, worth $2.06 Million. This represents 2.27% of its overall portfolio holdings.

Number of Shares

30,632

Previous 23,788 28.77%

Holding current value

$2.06 Million

Previous $2.05 Million 3.96%

% of portfolio

2.27%

Previous 1.91%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$69.3 - $90.95 $474,289 - $622,461	6,844 Added 28.77%	30,632 $2.13 Million
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $46,070 - $65,061	-542 Reduced 2.23%	23,788 $2.05 Million
Q3 2023 Nov 14, 2023	SELL	$90.94 - $199.54 $45,470 - $99,770	-500 Reduced 2.01%	24,330 $2.21 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $773,130 - $929,695	-5,842 Reduced 19.05%	24,830 $3.95 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $1.22 Million - $1.6 Million	-11,850 Reduced 27.87%	30,672 $4.15 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $58,597 - $71,911	615 Added 1.47%	42,522 $4.24 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $1.45 Million - $1.71 Million	-14,058 Reduced 25.12%	41,907 $4.67 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $640,248 - $773,937	6,877 Added 14.01%	55,965 $6.22 Million
Q4 2021 Nov 23, 2022	BUY	$95.88 - $117.08 $11,313 - $13,815	118 Added 0.24%	49,060 $5.5 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $11,313 - $13,815	118 Added 0.24%	49,088 $5.5 Million
Q3 2021 Nov 23, 2022	BUY	$84.42 - $106.62 $61,626 - $77,832	730 Added 1.51%	48,942 $4.7 Million
Q3 2021 Nov 08, 2021	BUY	$84.42 - $106.62 $63,990 - $80,817	758 Added 1.57%	48,970 $4.7 Million
Q2 2021 Nov 23, 2022	BUY	$67.66 - $84.76 $21,583 - $27,038	319 Added 0.67%	48,212 $4.04 Million
Q2 2021 Aug 13, 2021	BUY	$67.66 - $84.76 $23,478 - $29,411	347 Added 0.72%	48,212 $4.04 Million
Q1 2021 Nov 23, 2022	BUY	$67.06 - $75.82 $102,467 - $115,852	1,528 Added 3.3%	47,893 $3.23 Million
Q1 2021 May 12, 2021	BUY	$67.06 - $75.82 $100,590 - $113,729	1,500 Added 3.24%	47,865 $3.23 Million
Q4 2020 Nov 23, 2022	SELL	$63.89 - $73.8 $424,868 - $490,770	-6,650 Reduced 12.54%	46,365 $3.24 Million
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $424,868 - $490,770	-6,650 Reduced 12.54%	46,365 $3.24 Million
Q2 2020 Nov 23, 2022	SELL	$58.54 - $67.94 $237,087 - $275,157	-4,050 Reduced 7.1%	53,015 $3.47 Million
Q2 2020 Aug 05, 2020	SELL	$58.54 - $67.94 $237,087 - $275,157	-4,050 Reduced 7.1%	53,015 $3.47 Million
Q1 2020 Nov 23, 2022	BUY	$49.46 - $64.78 $774,790 - $1.01 Million	15,665 Added 37.84%	57,065 $3.44 Million
Q1 2020 Apr 30, 2020	BUY	$49.46 - $64.78 $774,790 - $1.01 Million	15,665 Added 37.84%	57,065 $3.44 Million
Q4 2019 Nov 23, 2022	SELL	$49.86 - $58.26 $55,942 - $65,367	-1,122 Reduced 2.64%	41,400 $2.4 Million
Q4 2019 Jan 27, 2020	BUY	$49.86 - $58.26 $2.06 Million - $2.41 Million	41,400 New	41,400 $2.4 Million

Others Institutions Holding NVO

# of Institutions

1,768

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $152B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Karani Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Karani Asset Management LLC with notifications on news.

Account

Karani Asset Management LLC Novo Nordisk A S Transaction History